UCI Startup, Hyperwall, OEM's Technology to Samsung
|
 |
Friday, 16 January 09 - 01:16 PM (GMT -08:00) By Bob Nidever in NEWS_Startups |
| ||
" If you like wide-screen TVs and computer monitors, check out Hiperwall's video wall technology. The startup has demonstrated its system running on 40 LCD monitors combined into a display that's 10-feet-high and 27-feet-across. Now, Samsung Electronics has agreed to distribute and support the super-sized, high-resolution displays.
" Hiperwall is a spin-off of the University of California at Irvine. The technology was developed at UC Irvine's California Institute for Telecommunications and Information Technology. Hiperwall, the company, was created a year ago to commercialize the technology, which goes by the same name. The deal with Samsung represents its first OEM distribution agreement. [InformationWeek] MORE
Electrical Geodesics, Inc. (EGI) Licenses Key Technology for EEG/fMRI Recording from UCLA
|
|
|
Wednesday, 26 November 08 - 01:22 PM (GMT -08:00) By Bob Nidever in NEWS_Licensing |
| ||
Eugene, Oregon - November 18, 2008 - New techniques for imaging the functional activity of the human brain by simultaneously recording changes in its electrical activity (EEG) and blood flow (fMRI) are contributing important insights into normal and pathological brain functioning. However, the EEG signal recorded with existing EEG/fMRI technologies is often of disappointing quality.
Today, EGI announced that it had licensed a key patent from The Regents of the University of California covering methods for improving the signal quality of the EEG when it is recorded during an MRI exam (U.S. Patent No. 7,286,871, “Method and apparatus for reducing contamination of an electrical signal”). The licensed techniques, developed by Dr. Mark Cohen of UCLA’s David Geffen School of Medicine, allow the artifact introduced into the recorded EEG signal by the large gradient pulses emitted by the MRI during its normal operation to be effectively removed from the data using timing pulses generated by the MRI. Additional claims in the patent protect the use of “twisted” pairs electrodes to help improve the signal-to-noise ratio, which also results in cleaner EEG recordings. [company pr] MORE
WaterStyle Holdings, Inc. and UCLA Announce an Exclusive License for Certain Advanced Technology for Water Sustainability
|
|
|
Wednesday, 19 November 08 - 01:55 PM (GMT -08:00) By Bob Nidever in NEWS_Startups |
| ||
" LOS ANGELES, Nov 19, 2008 (BUSINESS WIRE) -- WaterStyle Holdings, Inc. ("WSH") and UCLA jointly announce the licensing of certain key intellectual property for use in the water sector. The intellectual property focuses on advanced water systems, services and solutions for desalination, reclamation, reuse and sustainability. Under the terms of the License, WSH will have exclusive worldwide rights to this technology. This serves as the foundation for WSH's technology platform and systems capability.
" Some of unique features to these water technologies include smart water systems deploying advanced remote monitoring and control, rapid process diagnostic systems and field testing, membrane process monitors, high performance nano-structured membranes for nanofiltration and Reverse Osmosis ("RO") desalination, advanced processes for high recovery water desalination, and new methods for process optimization. The technologies developed by the UCLA WaTeR Center are pioneering technologies that have emerged from extensive multidisciplinary research and knowledgebase of fundamental science and technology. [marketwatch] MORE
Amyris: UC Berkeley Alternative Fuel Startup Opens Prototype Facility
|
|
|
Sunday, 16 November 08 - 12:39 PM (GMT -08:00) By Bob Nidever in NEWS_Startups |
| ||
"Yeast, when left to its own devices, eats sugar and secretes alcohol. Amyris has engineered it to eat sugar and secrete hydrocarbons instead.
That, in a nutshell, is the business plan for the company, a synthetic biology specialist that spun out of UC Berkeley. Through selective breeding and genetic engineering, the company has created a group of organisms that effectively release industry-standard fuels, chemicals or fuel precursors when they go to the bathroom.
The company grew out of research conducted by Jay Keasling and Jack Newman at Berkeley. The two were pioneers in the field of synthetic biology, which is the art/science of decoding natural processes in a lab and then trying to recreate them. Why can abalone create hard shells out of plain chalk? Synthetic biologists try to figure out questions like that. [greentechmedia] MORE
NanoPacific Announces Two New Exclusive Licensed Technologies Invented at UCLA -- Nanoemulsions and Polypeptides
|
|
|
Sunday, 16 November 08 - 12:19 PM (GMT -08:00) By Bob Nidever in NEWS_Licensing |
| ||
Wireless Healthcare Startups - UCSD Professor Launches Santech
|
|
|
Sunday, 16 November 08 - 11:50 AM (GMT -08:00) By Bob Nidever in NEWS_Startups |
| ||
" Santech uses accelerometers – the technology behind the motion-sensing Nintendo Wii – along with GPS and heart-rate monitors to track a participant's location and activity level. Information is sent from the sensors, via Bluetooth wireless to a phone, which relays it to Santech servers. [unionTribune] MORE
UCLA Startup, Solarmer Energy, Inc., to Present on Plastic Solar Cells with Greater than 5% Efficiency
|
|
|
Friday, 26 September 08 - 11:21 AM (GMT -08:00) By Bob Nidever in NEWS_Startups |
| ||
EL MONTE, CA--(Marketwire - September 26, 2008) - Dr. Vishal Shrotriya, Director of Technology Development, will present Solarmer Energy, Inc.'s progress toward delivering commercial grade plastic solar cells and future plans at the Organic Semiconductor Conference in Frankfurt, Germany on September 30, 2008. The talk will focus on three key efforts contributing to significant progress towards the company's goals: success in materials development leading to improvements in efficiency, an emphasis on making translucent solar cells a reality, and plans to prove the manufacturability of Solarmer's plastic solar cells.
"We are very excited about having the flexibility to work with three distinct polymer systems that have attained more than 5% efficiency in the lab," said Dr. Yue Wu, Senior Researcher and leader of Solarmer's Device Engineering team. "These results were made possible through the successful combination of the device engineering and materials development expertise of Solarmer and our partners, and will give us multiple routes to explore to achieve higher efficiency and successful delivery of our commercial grade prototype." [marketwire] MORE
UCSD Technology Licensed by Urigen Pharmaceuticals
|
|
|
Saturday, 13 September 08 - 06:13 PM (GMT -08:00) By Bob Nidever in NEWS_Licensing |
| ||
"For the millions of sufferers of a bladder condition called painful bladder syndrome/interstitial cystitis, hope is on the way, developed by urologic surgeon and researcher Lowell Parsons, M.D. of the University of California, San Diego Medical Center.
"What our team has identified is an experimental drug therapy that can provide pain relief to patients within 20 minutes," said Parsons, professor of surgery at UC San Diego School of Medicine. "Depending on the individual, in my experience, one dose can last from 6 to 40 hours. The ability of the therapy to provide immediate relief is something entirely new for sufferers of interstitial cystitis."
"The new drug therapy combination has been licensed by UC San Diego Technology Transfer & Intellectual Property Services to Urigen Pharmaceuticals, Inc. for further clinical development and commercialization. [MedicalNewsToday] MORE
UCI Startup, RF Nano, Receives $8M to Develop Carbon Nanotubes for High-performance Wireless Communications
|
|
|
Monday, 18 August 08 - 11:28 AM (GMT -08:00) By Bob Nidever in NEWS_Startups |
| ||
"Oxantium Ventures raised $8 million in venture capital to speed up technology development at RF Nano Corp., which makes radio frequency devices from carbon nanotubes.
The D.C.-based technology investment group led the round and Laguna Beach, Calif.-based Okapi Ventures, an existing RF Nano investor, also participated.
Newport Beach, Calif-based RF Nano is prepping its devices to dive into the $60 billion analog and mixed-signal communications markets. The three-year-old privately held company is targeting the sampling of its first products for the first quarter of 2009." [WashingtonBusinessJrnl] MORE
UCI Startup, Antigen Discovery Inc., Awarded SBIR Phase II Grant to Commericialize Novel Protein Microarray Based Platform
|
|
|
Friday, 01 August 08 - 09:52 AM (GMT -08:00) By Bob Nidever in NEWS_Startups |
| ||
"The major bottleneck that limits the translation of readily available genomic information into the development of next generation diagnostics, vaccines and therapeutics, is the continued lack of effective antigen and biomarker discovery tools," said Dr. Xiaowu Liang, CEO of ADI. "We are grateful that the SBIR program continues to fund ADI and our UCI collaborators in the further development of this exciting new technology platform that truly revolutionizes the screening and detection of disease markers." [prnewswire] MORE
Raptor Pharmaceutical Inc. Enters Collaboration Agreement with University of California, San Diego (UCSD) in Liver Disease
|
|
|
Thursday, 24 July 08 - 09:31 PM (GMT -08:00) By Bob Nidever in NEWS_Licensing |
| ||
Under the terms of the Agreement, clinical researchers from UCSD will perform the Phase 2a study at the University's General Clinical Research Center, and Raptor will provide funding and clinical supply of Cysteamine. In March 2008, Raptor acquired an exclusive, worldwide license to certain intellectual property and development rights from UCSD surrounding the use of Cysteamine as a potential treatment for NASH. [biospace] MORE
Nitride Solutions wins UCSB start-up prizes
|
|
|
Saturday, 05 July 08 - 10:03 PM (GMT -08:00) By Bob Nidever in NEWS_Startups |
| ||
" In this year’s University of California, Santa Barbara (UCSB) Technology Management Program New Venture Competition at the end of May $25,000 was distributed between five winners in different categories. Winning $10,000 and $5,000 in the ‘Most Fundable Idea’ and ‘Dow Materials Use’ categories, respectively, was the startup Nitride Solutions of Santa Barbara, CA, USA.
" Nitride Solutions is dedicated to commercializing a process developed in UCSB’s engineering labs for the manufacture of high-quality aluminum nitride (AlN) substrates, enabling the fabrication of low-cost, high-efficiency and long-life ultraviolet LEDs (used for sterilizing medical devices or biological detection) and electronic devices that are currently not commercially available. [semiconductorToday] MORE
Neoprobe Expands Access to UCSD Developed Technology
|
|
|
Monday, 12 May 08 - 03:08 PM (GMT -08:00) By Bob Nidever in NEWS_Licensing |
| ||
"DUBLIN, Ohio--(BUSINESS WIRE)--Neoprobe Corporation (OTCBB: NEOP), a diversified developer of innovative oncology and cardiovascular surgical and diagnostic products, today announced that Neoprobe and the University of California, San Diego (UCSD) have executed a definitive license agreement involving development rights to a molecular compound developed by researchers at UCSD. The new agreement accords Neoprobe the right to develop products using the compound for human medical applications incorporating optical or ultrasound technology. In addition, the development rights to the compound have been expanded to include veterinary applications. The compound is covered by U.S. patent 6,409,990 and corresponding issued patents in the European Union and Japan.
"William Decker, Assistant Director of the Office of Technology Transfer and Intellectual Property Services of UCSD, said, "We're pleased that our office could assist in working with Neoprobe to bring an additional use of this technology to the public at-large." [BusinessWire] MORE
UCSB takes role in diabetes drug project
|
|
|
Monday, 12 May 08 - 02:19 PM (GMT -08:00) By Bob Nidever in NEWS_Research |
| ||
" UC Santa Barbara has joined with drugmaker Pfizer and several institutions to foster research that could lead to better understanding and treatment of diabetes.
"Pfizer is putting up $14 million for the first three years of the project, one of the first of its kind. The project embraces a new approach to research that marks a shift in how university and pharmaceutical researchers work and serves as a model for the future, according to those involved in its creation.
'"We have a program at UCSB that is working very much at the interface of medicine and technology," said Frank Doyle, who is heading the project at the university. "Even in the absence of a medical school, we're able to work on partnerships with Big Pharma that are going to deliver enabling medical technology." [VenturaCountyStar]MORE
Startup Commercializes UCLA Technology for Wearable Artificial Kidney
|
|
|
Friday, 11 April 08 - 12:25 PM (GMT -08:00) By Bob Nidever in NEWS_Startups |
| ||
" Singapore – March 8, 2008: University of California, Los Angeles (UCLA) has entered into a world-wide, exclusive licensing agreement with AWAK Technologies Pte Ltd for the development and commercialization of a peritoneal-based automated wearable artificial kidney (AWAK) for the treatment of patients with end-stage renal disease (ESRD).
The peritoneal-based AWAK requires no extracorporeal circulation, and is therefore “bloodless”. It is designed to continuously regenerate and reuse the spent peritoneal dialysate in perpetuity and is, therefore, also “waterless”. A sorbent-based assembly regenerates both the aqueous and the protein components (AqC and PrC) of the spent peritoneal dialysate, and produces a novel, autologous protein-containing peritoneal dialysate. [BioSpace] MORE
An important feature of AWAK is that it is peritoneal dialysis-based. Current work by others on wearable artificial kidneys evolve around the technology of hemodialysis or hemofiltration, which require continuous anticoagulation of the extracorporeal circulation and are encumbered with potential immunologic and non-immunologic complications of continuous blood-artificial membrane interactions. Continuous extracorporeal circulation also exposes patients to the constant risk of exsanguinations through accidental disruption of the blood circuit. Prior clinically evaluated hemofiltration-based wearable artificial kidneys have consistently failed because of clotting within a week, in spite of aggressive anticoagulation.
... More items are available in my News Archive
